The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TBPH FINANCIAL STATEMENTS

Theravance Biopharma Inc — balance sheet, income statement and cash flow trends

TBPHTheravance Biopharma Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M20202021202420252026

Profit Funnel

Q1 2026 · TTM
Revenue109.8 M $Gross Profit88.2 M $ · 80%Operating Income88 K $ · 0%Pre-tax Income136.9 M $ · 125%Net Income to Owners114.5 M $ · 104%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue109.8 M $+68.2%
Gross Profit88.2 M $+251.0%
Operating Income88 K $—
EBITDA142.5 M $—
Net Income to Owners114.5 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M20202021202420252026

Capital Structure

Q1 2026
Total Assets472.3 M
  • Equity290.6 M $62%
  • Current Liabilities31.8 M $7%
  • Long-term Liabilities149.9 M $32%

Key Figures

YoY change
Total Assets472.3 M $+37.5%
Total Liabilities181.7 M $+2.3%
Total Equity290.6 M $+75.1%
Cash & ST Investments394.7 M $+201.6%
Total Debt73.3 M $+52.2%
Net Debt-214.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0200 M20202021202420252026

Cash Flow Bridge

Q1 2026 · TTM
0100 M200 M268.8 M $Operating-83.3 M $Investing-8 M $Financing177.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow268.8 M $+726.4%
Capital Expenditures42 K $-82.6%
Free Cash Flow268.7 M $+732.4%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TBPH

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.